Wells Fargo’s Keros Therapeutics KROS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $293K | Buy |
21,945
+5,167
| +31% | +$69K | ﹤0.01% | 4140 |
|
|
2025
Q1 | $171K | Buy |
16,778
+1,570
| +10% | +$16K | ﹤0.01% | 4368 |
|
|
2024
Q4 | $241K | Buy |
15,208
+4,153
| +38% | +$65.7K | ﹤0.01% | 4198 |
|
|
2024
Q3 | $642K | Sell |
11,055
-464
| -4% | -$26.9K | ﹤0.01% | 3477 |
|
|
2024
Q2 | $526K | Buy |
11,519
+2,210
| +24% | +$101K | ﹤0.01% | 3550 |
|
|
2024
Q1 | $616K | Buy |
9,309
+3,363
| +57% | +$223K | ﹤0.01% | 3418 |
|
|
2023
Q4 | $236K | Sell |
5,946
-9,292
| -61% | -$369K | ﹤0.01% | 3993 |
|
|
2023
Q3 | $486K | Sell |
15,238
-6,085
| -29% | -$194K | ﹤0.01% | 3529 |
|
|
2023
Q2 | $857K | Buy |
21,323
+7,016
| +49% | +$282K | ﹤0.01% | 3383 |
|
|
2023
Q1 | $611K | Buy |
14,307
+14,260
| +30,340% | +$609K | ﹤0.01% | 3474 |
|
|
2022
Q4 | $2.26K | Sell |
47
-618
| -93% | -$29.7K | ﹤0.01% | 5659 |
|
|
2022
Q3 | $25K | Sell |
665
-3,512
| -84% | -$132K | ﹤0.01% | 4966 |
|
|
2022
Q2 | $115K | Buy |
4,177
+2,694
| +182% | +$74.2K | ﹤0.01% | 4309 |
|
|
2022
Q1 | $81K | Sell |
1,483
-5,351
| -78% | -$292K | ﹤0.01% | 5100 |
|
|
2021
Q4 | $400K | Buy |
6,834
+6,831
| +227,700% | +$400K | ﹤0.01% | 4512 |
|
|
2021
Q3 | $0 | Sell |
3
-6
| -67% | – | ﹤0.01% | 6905 |
|
|
2021
Q2 | $0 | Sell |
9
-422
| -98% | – | ﹤0.01% | 6805 |
|
|
2021
Q1 | $27K | Sell |
431
-19,083
| -98% | -$1.2M | ﹤0.01% | 5706 |
|
|
2020
Q4 | $1.38M | Buy |
19,514
+6,992
| +56% | +$493K | ﹤0.01% | 3728 |
|
|
2020
Q3 | $483K | Buy |
12,522
+499
| +4% | +$19.2K | ﹤0.01% | 4257 |
|
|
2020
Q2 | $451K | Buy |
+12,023
| New | +$451K | ﹤0.01% | 4285 |
|